Comparative risk of hepatocellular carcinoma in patients with chronic hepatitis B receiving tenofovir- or entecavir-based regimens: a meta-analysis using individual patient data

Conference Reports for NATAP

The International Liver Congress™
EASL - European Association for the
Study of the Liver
June 22-26 2022


Comparative risk of hepatocellular carcinoma in patients with chronic hepatitis B receiving tenofovir- or entecavir-based regimens: a meta-analysis using individual patient data

	EASL 2022 June 22-26 London